electroCore, Inc. (ECOR)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about electroCore, Inc. (ECOR)
Go deeper and ask any question about ECOR
Company Performance
Current Price
as of Sep 13, 2024$6.10
P/E Ratio
N/A
Market Cap
$39.33M
Description
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
Metrics
Overview
- HQRockaway, NJ
- SectorHealth Technology
- IndustryMedical Specialties
- TickerECOR
- Price$6.1+4.27%
Trading Information
- Market Cap$39.33M
- Float81.11%
- Average Daily Volume (1m)9,876
- Average Daily Volume (3m)9,276
- EPS-$2.19
Company
- Revenue$21.28M
- Rev Growth (1yr)72.88%
- Net Income-$2.66M
- Gross Margin86.35%
- EBITDA Margin-38.51%
- EBITDA-$2.36M
- EV$34.80M
- EV/Revenue1.64
- P/EN/A
- P/S2.02
Documents
SEC Filings
Factset Street Account
Factset